Initially approved at doses of 0.5 mg and 1.0 mg once weekly, it has subsequently received authorisation for a 2.0 mg once-weekly dose for the management of type 2 diabetes
Lawsuits are being filed nationwide against Novo Nordisk, the drugs manufacturer, for failing to adequately warn consumers about serious side effects such as gastroparesis, stomach paralysis, prolonged nausea, and bowel obstruction
Both high and low potassium are serious conditions and need to be managed properly
Why do different semaglutide vials have different concentrations
The medication also affects how quickly food moves through your entire digestive tract, causing either diarrhoea when digestion moves too fast or constipation when it moves too slowly
The emerging research: what scientists are studying now The relationship between GLP-1 therapy and urinary health is an active area of investigation, and several research threads deserve attention